Results 141 to 150 of about 17,093 (242)

Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cells [PDF]

, 2020
openaire   +1 more source

The Cytotoxic Potential of Humanized γδ T Cells Against Human Cancer Cell Lines in <i>In Vitro</i>. [PDF]

Cells
Michael H, Lenihan AT, Vallas MM, Weng GW, Barber J, He W, Chen E, Sheiffele P, Weng W.   +8 more
europepmc   +1 more source

Editorial: Community series in the role of CD1- and MR1-restricted T cells in immunity and disease: volume III. [PDF]

Front Immunol
Iwabuchi K, Van Kaer L.
europepmc   +1 more source

Very late-onset Krabbe disease with concomitant dementia: case description and a critical review of the literature. [PDF]

Neurol Sci
Rossi S, Tessa A, Vita MG, Russo R, Parisi D, Piemonte F, Dalla Zanna G, Santorelli FM, Silvestri G.   +8 more
europepmc   +1 more source

Versatile synthesis of C-5" and C-6"-modified α-GalCer analogues as new iNKT cell ligands [PDF]

, 2012
ASPESLAGH, SANDRINE, Elewaut, Dirk, Pauwels, Nora, Van Calenbergh, Serge   +3 more
core   +1 more source

Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice.

Journal of Molecular and Cellular Cardiology, 2013
Tsuneaki Homma, S. Kinugawa, Masashige Takahashi, M. A. Sobirin, A. Saito, A. Fukushima, T. Suga, S. Takada, Tomoyasu Kadoguchi, Yoshihiro Masaki, T. Furihata, M. Taniguchi, T. Nakayama, Naoki Ishimori, K. Iwabuchi, H. Tsutsui   +15 more
semanticscholar   +1 more source

Highly Potent Th1-Type NKT Cell Agonists as Immunotherapeutic Agents via Conformational Restriction Design. [PDF]

JACS Au
Wen Y, Wu YH, Sun QN, Wang EY, Luo MQ, Fu ZR, Zhou Z, Mei DX, Guo J.   +8 more
europepmc   +1 more source

PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumors. [PDF]

J Immunother Cancer
Burks J, Tiwary S, Stevens DM, Skoczen SL, Kularatne RN, Stern ST, Berzofsky JA.   +6 more
europepmc   +1 more source

Multiple cell-type interactions drive invariant NKT cell hepatitis. [PDF]

Hepatol Commun
Tan J, Ji L, Li Q, Guo R, Hao Y, Xiao P, Zai Q, Zhang X, Gao Y, Zhang X, Fang M, Gao Y, Zhao W, He Y, Gao Y, Li M.   +15 more
europepmc   +1 more source

Intratumoral dendritic cell immunotherapy controls dissemination of metastasis-initiating cancer cells, even in patients with metastatic breast cancer. [PDF]

J Immunother Cancer
Soyano A, Lee MC, Han HS, Aldrich A, Soliman H, Olson-Mcpeek SK, Balsay-Patel CN, Aiello P, Farrell CM, Weinfurtner R, Burgos E, Czerniecki BJ, Ramamoorthi G.   +12 more
europepmc   +1 more source